They weren’t enough. But then Golden turned to glucagon-like peptide 1 (GLP-1) receptor agonists, and they delivered. Leslie Golden, MD, MPH, DABM “She did lose a significant amount of weight ...

The adjunctive use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) as an addition to insulin ... In Garg’s own pilot study, a retrospective chart review of 50 patients with T1D and ...

Our data is able to show our employer clients the impact of their pharmacy spend on their overall healthcare expenses Demand for GLP medications ... The results in the chart below show how these ...

GLP-1 drugs indirectly reduce inflammation through weight loss. The meds can also activate certain T cells — white blood cells key to the immune system — which can have anti-inflammatory effects.

While GLP-1 receptor agonists like semaglutide help with weight loss, new research shows users often fall short on vital nutrients, spotlighting the urgent need for tailored dietary guidance.

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has arrived on the scene with an eye-popping series A. The London ...

Key Trends in GLP-1 RA Usage The research revealed significant variations in prescribing patterns. Liraglutide accounted for ...